- New
Understanding the early signs of cardiac amyloidosis
Explore the early warning signs and symptoms of amyloidosis and understand if they may point to ATTR-CM—a type of cardiac amyloidosis caused by abnormal TTR proteins.
Key takeaways
Amyloidosis is the term for a group of rare diseases caused by the buildup of abnormal proteins, called amyloid, in organs and tissues. Over time, these proteins can interfere with normal body function. There are several types of amyloidosis, and while they share some symptoms, they are distinct in cause and impact.
One type, ATTR-CM (transthyretin cardiac amyloidosis), primarily affects the heart and is caused by a mutation of TTR (transthyretin) proteins. These proteins misfold and form amyloid deposits in the heart muscle, making it stiff and less able to pump blood effectively. ATTR-CM is a form of amyloidosis, but not all amyloidosis is ATTR-CM.
Early signs and symptoms of ATTR-CM
ATTR-CM can be difficult to diagnose because its symptoms often resemble those of more common conditions like heart failure. However, there are several early signs and symptoms that may point to ATTR-CM:
General symptoms
- Fatigue or shortness of breath during everyday activities
- Swelling in the legs, ankles, or feet
- Bloating in the abdomen
Neurological symptoms
- Numbness or tingling in the hands and feet (peripheral neuropathy)
- Carpal tunnel syndrome
- Dizziness or fainting
Gastrointestinal symptoms
- Diarrhea or constipation
- Unexplained weight loss
- Feeling full quickly
- Nausea
Cardiac symptoms
- Irregular heartbeat or palpitations
- Chest discomfort
- Signs of heart failure (fluid retention, fatigue, breathlessness)
Other physical signs
- Biceps tendon rupture
- Difficulty climbing stairs or walking long distances
You can take a free ATTR-CM Assessment to understand the risk factors and help guide your conversation with a doctor. If you're looking for a specialist, the Doctor Finder tool can help.
Time is a precious thing and something many take for granted. I was unsure what milestones in my family members’ lives I would see after my ATTR-CM diagnosis. As of today, I have seen my older son pick his career, watched my younger son write music and learn to play the trumpet. I never thought I would be here to see all this.”
Faye, ATTR-CM patient
wtATTR vs. hATTR: two forms of ATTR
There are two main types of ATTR:
Wild-type ATTR-CM (wtATTR)
Wild-type ATTR (wild-type transthyretin amyloidosis) develops with age is more common in older adults, especially men 60+. “Wild-type” refers to the fact that as people grow older, TTR proteins with a normal (non-mutated) genetic sequence can become unstable and misfold. When that happens, the misfolded proteins build up in different organs and tissues as amyloid.
While the heart is the main organ affected, amyloid deposits can also accumulate in other tissues, causing non-heart symptoms like carpal tunnel syndrome or lumbar spinal stenosis that often precede heart symptoms by several years.
Because symptoms can be vague, progress slowly, and often occur alongside other age-related heart conditions, wtATTR is often misdiagnosed as general aging or other heart-related issues.
wtATTR is more common than hATTR (hereditary transthyretin amyloidosis).
Hereditary ATTR (hATTR)
Hereditary ATTR (hereditary transthyretin amyloidosis) is caused by a mutation in the gene responsible for producing the transthyretin (TTR) protein. When that gene is altered, it can cause the TTR protein to fold incorrectly.
The main types of hATTR are generally categorized by the main organ system affected. hATTR-CM (cardiomyopathy) mainly affects the heart, while hATTR-PN (polyneuropathy) primarily affects the peripheral and autonomic nervous systems.
hATTR is more common in certain ethnic groups, such as Black, African American, and Afro-Caribbean communities, amongst others. More than 100 different TTR mutations have been identified, and the age at which symptoms appear can vary depending on the specific mutation. In the United States, the most common mutation is Val122Ile, which is found in approximately 3–4% of African Americans, although being a carrier does not mean you will develop the disease.
Other types of amyloidosis
Beyond wtATTR and hATTR, there are several other forms of amyloidosis, each with its own set of symptoms and causes. These include:
- AL amyloidosis is caused by abnormal light chains produced by plasma cells. It can lead to bruising around the eyes (periorbital purpura), an enlarged tongue (macroglossia), nerve pain, heart problems, and kidney dysfunction.
- AA amyloidosis is typically linked to chronic inflammatory diseases such as rheumatoid arthritis or inflammatory bowel disease. It often affects the kidneys and gastrointestinal tract.
- Dialysis-related amyloidosis can occur in people who have been on long-term dialysis. It often affects the bones and joints, causing pain and stiffness.
Each type of amyloidosis presents differently, but all involve the buildup of amyloid proteins that disrupt normal organ function.
ATTR-CM can be tricky to diagnose
ATTR-CM is often underdiagnosed because its symptoms can mimic other conditions. But early recognition can lead to better outcomes. If you or someone you care about is experiencing unexplained symptoms such as fatigue, swelling, nerve pain, or digestive issues, it’s important to speak with a healthcare provider.
Before we knew it was hereditary ATTR-CM, I was diagnosed with carpal tunnel syndrome, which I first attributed to my previous career as a college professor. I also began noticing tingling in my arms and legs, and shortness of breath during routine jogs.”
Randy, hATTR-CM patient
Who is more likely to develop ATTR-CM?
ATTR-CM is more frequently seen in certain populations. wtATTR-CM is most common in older adults and tends to affect men ages 60+ more than women. People with a family history of amyloidosis may be at higher risk for hATTR, while wtATTR can occur without any genetic link.
Individuals of African American descent may also be at increased risk for specific hereditary mutations associated with hATTR. Recognizing these patterns can help guide conversations with healthcare providers, especially when symptoms are present but unexplained.
Take action if you suspect ATTR-CM
If you’re noticing unexplained symptoms such as carpal tunnel, spinal stenosis, and tingling or numbness in extremities, coupled with symptoms like shortness of breath, it may be worth exploring whether ATTR-CM could be a factor. Understanding the early signs and knowing your risks can help you have more informed conversations with your doctor. You can start by taking the free ATTR-CM Assessment or using the Doctor Finder to connect with a specialist near you.
Frequently
asked questions
Are there treatments for ATTR-CM?
Yes. While there’s no cure, there are treatments for ATTR-CM that can help slow disease progression. Early diagnosis and treatment can lead to better outcomes.
The free ATTR-CM Assessment can help you understand the risk factors and help guide your conversation with a doctor.
Is ATTR-CM common?
ATTR-CM is considered rare but may be more common than previously thought—especially among older adults.
Why is ATTR-CM underdiagnosed?
ATTR-CM symptoms often resemble other conditions like heart failure, making it easy to overlook. Learn more about how ATTR-CM is diagnosed and how to talk to your doctor about ATTR-CM.
If I have symptoms that may be ATTR-CM, what should I do?
If you suspect ATTR-CM, talk to your doctor about your symptoms and ask whether ATTR-CM could be a possibility. The Doctor Finder can help you connect with a specialist near you. Because ATTR-CM is often misdiagnosed or overlooked, being proactive is key.
More relevant articles
Keep reading
- Recommended
How ATTR-CM is diagnosed
ATTR-CM can often be hard to diagnose. Find out about diagnosis and what you can do to help detect it early.
4 min read
- New
How to talk to your doctor about ATTR-CM
Get ready for a conversation about your symptoms, diagnosis, and treatment options.
4 min read
- Lifestyle
Support groups and resources for ATTR-CM
Explore the early warning signs and symptoms of amyloidosis and find out if they could point to ATTR-CM.
4 min read
References
American Heart Association. Transthyretin Amyloid Cardiomyopathy (ATTR-CM). May 29, 2024. Accessed November 2025. https://www.heart.org/en/health-topics/cardiomyopathy/what-is-cardiomyopathy-in-adults/transthyretin-amyloid-cardiomyopathy-attr-cm.
Ash S, Shorer E, Ramgobin D, et al. Cardiac amyloidosis-A review of current literature for the practicing physician. Clin Cardiol. 2021;44(3):322-331. doi:10.1002/clc.23572
Baker KR, Rice L. The Amyloidoses: Clinical Features, Diagnosis, and Treatment. Methodist Debakey Cardiovasc J. 2012;8(3):3-7.
Conceição I, Damy T, Romero M, et al. Early Diagnosis of ATTR Amyloidosis Through Targeted Follow-up of Identified Carriers of TTR Gene Mutations. Amyloid. 2019;26(1):3-9. doi.org/10.1080/13506129.2018.1556156
Jain A, Zahra F. Transthyretin Amyloid Cardiomyopathy (ATTR-CM) [Updated 2023 Apr 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK574531/ Accessed November 2025
Kittleson MM, Ruberg FL, et al. 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023;81(11):1076-1126. doi:10.1016/j.jacc.2022.11.022
MedlinePlus. Amyloidosis. January 2, 2017. Accessed November, 2025. https://medlineplus.gov/amyloidosis.html.
Witteles RM, Bokhari S, Damy T, et al. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice. J Am Coll Cardiol HF. 2019;7(8):709-716.